<DOC>
	<DOC>NCT02122692</DOC>
	<brief_summary>To examine the effect of the strong CYP3A4/5 inhibitor itraconazole (200 mg QD) on the multipledose exposure of Lu AE58054 (30 mg QD) in healthy subjects (CYP2D6 extensive metabolisers).</brief_summary>
	<brief_title>Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Subjects are eligible for inclusion into the study if they meet each of the following criteria: Men and women, aged 18 45 years. Body weight at least 50 kg and Body Mass index 19 28 kg/m2. Good general health ascertained by a detailed medical history, laboratory tests and physical examination. Nonchildbearing potential or use of contraception (both sexes). Women must not be pregnant or lactating. Known CYP2D6 genotype (Extensive metaboliser (n=15) and poor metaboliser (n =5)) . Other Inclusion and Exclusion Criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>